A translational synthetic biology platform for rapid access to gram-scale quantities of novel drug-like molecules.
A translational synthetic biology platform for rapid access to gram-scale quantities of novel drug-like molecules.
复制标题
DOI:
10.1016/j.ymben.2017.06.012
复制
发表时间:
2017-07
影响因子:
8.4
通讯作者:
Osbourn A
中科院分区:
文献类型:
--
作者:
Reed J;Stephenson MJ;Miettinen K;Brouwer B;Leveau A;Brett P;Goss RJM;Goossens A;O'Connell MA;Osbourn A
Plants are an excellent source of drug leads. However availability is limited by access to source species, low abundance and recalcitrance to chemical synthesis. Although plant genomics is yielding a wealth of genes for natural product biosynthesis, the translation of this genetic information into small molecules for evaluation as drug leads represents a major bottleneck. For example, the yeast platform for artemisinic acid production is estimated to have taken >150 person years to develop. Here we demonstrate the power of plant transient transfection technology for rapid, scalable biosynthesis and isolation of triterpenes, one of the largest and most structurally diverse families of plant natural products. Using pathway engineering and improved agro-infiltration methodology we are able to generate gram-scale quantities of purified triterpene in just a few weeks. In contrast to heterologous expression in microbes, this system does not depend on re-engineering of the host. We next exploit agro-infection for quick and easy combinatorial biosynthesis without the need for generation of multi-gene constructs, so affording an easy entrée to suites of molecules, some new-to-nature, that are recalcitrant to chemical synthesis. We use this platform to purify a suite of bespoke triterpene analogs and demonstrate differences in anti-proliferative and anti-inflammatory activity in bioassays, providing proof of concept of this system for accessing and evaluating medicinally important bioactives. Together with new genome mining algorithms for plant pathway discovery and advances in plant synthetic biology, this advance provides new routes to synthesize and access previously inaccessible natural products and analogs and has the potential to reinvigorate drug discovery pipelines. Transient plant expression technology provides rapid access to diverse triterpenes. Gram-scale quantities of purified triterpene can be generated. Agro-infiltration can be exploited for quick and easy combinatorial biosynthesis. Bespoke known and new-to-nature compounds can be generated. The platform allows isolation of analogs for structure-activity investigations.
登录
查看更多内容
DOI:
10.1002/anie.201510650
发表时间:
2016-02-05
期刊:
Angewandte Chemie (International ed. in English)
影响因子:
--
作者:
Andersen-Ranberg J;Kongstad KT;Nielsen MT;Jensen NB;Pateraki I;Bach SS;Hamberger B;Zerbe P;Staerk D;Bohlmann J;Møller BL;Hamberger B
通讯作者:
Hamberger B
影响因子:
27.5
作者:
Biazzi, Elisa;Carelli, Maria;Calderini, Ornella
通讯作者:
Calderini, Ornella
DOI:
10.1126/science.aac9373
发表时间:
2015-09-04
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Galanie S;Thodey K;Trenchard IJ;Filsinger Interrante M;Smolke CD
通讯作者:
Smolke CD
影响因子:
14.8
作者:
Geu-Flores, Fernando;Nielsen, Morten Thrane;Halkier, Barbara Ann
通讯作者:
Halkier, Barbara Ann
影响因子:
3.8
作者:
Moses, Tessa;Thevelein, Johan M.;Pollier, Jacob
通讯作者:
Pollier, Jacob